SENSEX    73901.53       252.91    |    NIFTY    22416.05       79.65 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Sun Pharma in focus after unit files patent case against German firm
12-Jul-18   08:21 Hrs IST

Sun Pharmaceutical Industries said that its wholly-owned subsidiary, DUSA Pharmaceuticals, filed trade secret misappropriation and tortious interference claims in an ongoing patent infringement lawsuit against Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG in the United States District Court for the District of Massachusetts. The announcement was made after market hours yesterday, 11 July 2018.

The lawsuit alleges patent infringement of DUSA's patents covering DUSA's product, Levulan and Kerastick (aminolevulinic acid HCl) for topical solution, 20% used with DUSA's BLU-U Blue Light Photodynamic Therapy Illuminator. DUSA additionally alleges that the Biofrontera defendants misappropriated confidential and trade secret information from DUSA and improperly obtained confidential DUSA information from former DUSA employees to sell and market defendants' own products. The lawsuit seeks an assessment of both damages and injunctive relief against the Biofrontera defendants.

The patents-in-suit concern an apparatus and method for photodynamic therapy (or PDT) and equipment for PDT. The photodynamic therapy, pioneered by DUSA, combines a drug with a light source to treat disease conditions. The product was launched by DUSA in September 2000 in the US.

Coffee Day Enterprises announced that its material subsidiary, Coffee Day Global (CDGL), has entered in to an agreement with UBER Portier.B.V wherein CDGL is partnering with UBER for obtaining technology services through the 'UberEats' mobile application in order to enable distribution of food products. This may help to augment the retail sale. Tenure for the contract shall be for a period of 5 years. The announcement was made after market hours yesterday, 11 July 2018.

Power Grid Corporation of India announced that its wholly-owned subsidiary, Powergrid Warora Transmission, secured through tariff based competitive bidding (TBCB), has successfully put the elements into commercial operation progressively from November 2016 and the entire project put into commercial operation by 10 July 2018. The announcement was made after market hours yesterday, 11 July 2018.

Omaxe said it has executed a concession agreement with North Delhi Municipal Corporation (North DMC) on 10 July 2018 for the redevelopment/reconstruction of multi level car parking at Gandhi Maidan, Delhi. The announcement was made after market hours yesterday, 11 July 2018.

Shree Ajit Pulp And Paper has received a export order for supply of 1240 MT kraft paper valued approximately Rs 4.06 crore, which will be executed up to 15 August 2018. The announcement was made after market hours yesterday, 11 July 2018.

Satin Creditcare Network said its board approved the proposed transfer of the company's MSME business to wholly-owned subsidiary (WOS) upon its incorporation and registration of such WOS as a non-banking financial company with Reserve Bank of India. Incorporation of the wholly owned subsidiary of the company, subject to necessary approvals. Further, the board also approved acquisition of 11.05 lakh equity shares of Taraashna Services (a subsidiary of Satin Creditcare Network) by the company from MV Mauritius (an existing shareholder of Taraashna Services) that would result in Taraashna Services becoming a wholly owned subsidiary of the company. The announcement was made after market hours yesterday, 11 July 2018.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 88.89 1.07
United Kingdom (GBP) 1.16 1.00 103.18 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.81 83.42 1.00
Market News << ALL News
  23-Apr-2024, (12:19 )  Shish Inds hits the ..
  23-Apr-2024, (12:15 )  Oriental Aromatics L..
  23-Apr-2024, (12:09 )  Mahindra Logistics r..
  23-Apr-2024, (12:03 )  NSE SME Ramdevbaba S..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)